Translate to...

India#39;s Hetero Labs wins approval to launch COVID-19 drug favipiravir

India#39;s Hetero Labs wins approval to launch COVID-19 drug favipiravir
The drug, priced at 59 rupees (79 cents) per tablet, will be available at drug stores from Wednesday, privately held Hetero said.